PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism

Authors:

Abstract
No abstract available
Funding Information
  • Natural Science Foundation of Tianjin Municipality (21JCZDJC00060)
  • National Natural Science Foundation of China (81902826, 81672781, 81973356, 91957120)
  • State Key Laboratory of Drug Research, Chinese Academy of Sciences (SIMM2105KF-08)
  • Fundamental Research Funds for the Central Universities (3206054, 92122017, 91923101, 63213082)
  • National Key Research and Development Program of China (2018YFC2002000)

This publication has 25 references indexed in Scilit: